AgeX Therapeutics announces a manufacturing, marketing and distribution agreement with Pluristyx, an advanced therapy tools and services company, to expand access to clinical-grade human pluripotent stem cells for therapeutic applications.
LyGenesis announces four new peer-reviewed publications highlighting its advancing technology for kidney and liver regeneration.
iTolerance and LyGenesis announced a collaboration to evaluate the potential of iTOL-201 combined with LyGenesis' liver cell therapy (LYG-LIV-100), to enable ectopic livers to be grown without the need or immune...
Juvenescence joins the 200M Fund portfolio in the investment in Chrysea Labs (“Chrysea”), a synthetic biology company developing high-value and difficult to source natural products, using proprietary synthetic biology platforms.
Upcoming Events, Conferences & Webinars
[Conference) Web Summit 2022 | LisbonSIGN UP
November 1-4, 2022
Web Summit 2022 will bring together 70,000+ people, and the companies redefining the tech industry.
Replays from Events, Conferences & Webinars
[Conference] MasterInvestor Show 2022WATCH NOW
Dr. Greg Bailey and Jim Mellon at Master Investor's flagship event for private investors, ‘The Master Investor Show’. This conference includes presentations from leading companies and experts within the financial and investment sectors.
[Webinar] Investing in the Future of Longevity – the Ketone ChapterWATCH NOW
Dr. Gregory Bailey, MD and Jim Mellon, co-founders of Juvenescence, brought together the leading experts in ketone metabolism and longevity to discuss new science regarding ketones, new investment opportunities, and an exciting, new Rx development initiative from Juvenescence.
[Conference] Investing in the Age of Longevity 2021WATCH NOW
The lifespan revolution is coming – find out how to connect, collaborate and invest. Dr. Greg Bailey and Jim Mellon will be giving presentations about investment opportunities and the future of the industry.